Latest Period
Q2 2026
Security Snapshot
Indivior Pharmaceuticals, Inc. - Common stock, $0.001 par value per share (INDV) Institutional Ownership
CUSIP: 45579U109
13F Institutional Holders and Ownership History from Q4 2025 to Q2 2026
Institutions Reporting
335
Shares (Excl. Options)
121,405,303
Price
$41.03
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, $0.001 par value per share
- Symbol
- INDV on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 121,405,303
- Total 13F value
- $4,979,660,938
- Portfolio coverage rank
- 0.01%
- Share change
- -5,507,090
- Value change
- -$193,756,208
- Number of holders
- 335
- Shares outstanding
- 119,612,237
- SEC-reported price per share
- $40.22
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- INDV - Indivior Pharmaceuticals, Inc. - Common stock, $0.001 par value per share is tracked under CUSIP 45579U109.
- 335 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 287 to 335 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $3,887,638,701 to $4,979,660,938.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 335 institutions filings for Q2 2026.
Security key
45579U109
Latest holder period
Q2 2026
13F holders
335
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
INDV full holder history
Indivior Pharmaceuticals, Inc. SEC filings
Indivior Pharmaceuticals, Inc. company facts
Indivior Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45579U109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
INDV
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Oaktree Capital Holdings, LLC | 0.76% | $36,589,383 | 909,053 | Oaktree Capital Holdings, LLC | 11 Aug 2026 |
As of 30 Jun 2026, 335 institutional investors reported holding 121,405,303 shares of Indivior Pharmaceuticals, Inc. - Common stock, $0.001 par value per share (INDV). This represents 101% of the company’s total 119,612,237 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
74%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 16% | 18,709,432 | +0.9% | 0.01% | $767,647,995 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.3% | 7,572,287 | -4% | 0.01% | $310,690,936 |
| OAKTREE CAPITAL MANAGEMENT LP | 5.1% | 6,127,212 | -12% | 4.7% | $251,399,508 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.6% | 5,495,486 | -1.6% | 0% | $225,479,791 |
| STATE STREET CORP | 4.2% | 4,992,071 | +1.8% | 0.01% | $204,824,673 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 3.9% | 4,615,816 | +1.9% | 0.52% | $189,386,924 |
| Two Seas Capital LP | 2.9% | 3,479,493 | -27% | 5.4% | $142,763,598 |
| MORGAN STANLEY | 2.8% | 3,395,702 | -3.1% | 0.01% | $139,325,692 |
| FRANKLIN RESOURCES INC | 2.8% | 3,316,358 | +2872% | 0.03% | $136,070,167 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 3,159,866 | +8% | 0.01% | $129,675,346 |
| Madison Avenue Partners, LP | 2.4% | 2,874,368 | -33% | 5.1% | $117,935,319 |
| MANGROVE PARTNERS IM, LLC | 2.2% | 2,676,730 | -2.4% | 7.2% | $109,826,232 |
| CITADEL ADVISORS LLC | 2.2% | 2,667,827 | -25% | 0.06% | $109,460,942 |
| Driehaus Capital Management LLC | 1.9% | 2,299,054 | +22% | 0.55% | $94,330,186 |
| MILLENNIUM MANAGEMENT LLC | 1.8% | 2,098,945 | -54% | 0.06% | $86,119,713 |
| DIMENSIONAL FUND ADVISORS LP | 1.6% | 1,896,605 | +42% | 0.01% | $77,819,163 |
| Invesco Ltd. | 1.5% | 1,842,983 | +18% | 0.01% | $75,617,592 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.4% | 1,648,895 | -47% | 0.71% | $67,654,162 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.4% | 1,642,086 | -29% | 0.03% | $67,374,789 |
| Assenagon Asset Management S.A. | 1.3% | 1,540,928 | 0.08% | $63,224,276 | |
| FEDERATED HERMES, INC. | 1.2% | 1,468,749 | +21% | 0.09% | $60,262,772 |
| Newtyn Management, LLC | 1.1% | 1,305,795 | -35% | 6.7% | $53,576,769 |
| Point72 Asset Management, L.P. | 1% | 1,250,639 | +1217% | 0.08% | $51,313,718 |
| NORTHERN TRUST CORP | 1% | 1,241,772 | +6.9% | 0.01% | $50,949,904 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1% | 1,224,609 | +7.2% | 0.01% | $50,245,707 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Latest
Q2 2026
Rows shown
1-3 of 3